Risperdal Lawsuits

Risperdal is a prescription drug intended to treat neurological conditions such as schizophrenia, autism, bipolar disorder, and acute mania, generally in youth. The Food and Drug Administration (FDA) approved Risperdal in the U.S. in 1993. Since then, many patients have experienced increased levels of prolactin and related breast and nipple complications while taking the drug.

If you or a loved one has experienced adverse health effects after taking Risperdal, call our attorneys today. You may have grounds for a lawsuit against the drug maker, Ortho-McNeil-Janssen Pharmaceuticals (or parent company Johnson & Johnson). Our lawyers are investigating cases involving Risperdal. We may be able to help you obtain compensation for your damages in Kansas City. Call today for your free consultation.

Why Choose Us?

It is important to find an attorney that makes you feel confident in the success of your case. Different law firms near you will have different levels of experience handling defective drug cases. The Dickerson Oxton Law Firm has the track record of success that demonstrates our attorneys’ dedication to positive outcomes.

  • Initial consultations with our attorneys are always free, confidential, and zero-obligation.
  • We do not charge attorney’s fees unless we win.
  • Our lawyers take a passionate, client-first stance on personal injury law.
  • Our firm has extensive experience handling Risperdal and other bad drug lawsuits.

If you want to have peace of mind for the duration of your Risperdal claim, count on our attorneys to represent your case. We know how to navigate federal and state product liability laws in both Missouri and Kansas. We can help your family obtain justice for Risperdal side effects.

What Is Risperdal? What Are the Issues?

Patients are seeking financial compensation from Ortho-McNeil-Janssen Pharmaceuticals regarding Risperdal because the drug is allegedly causing the formation of breast tissue (gynecomastia) in young males, as well as premature breast tissue development and lactation in young girls and women. Young males with gynecomastia may require surgical intervention to remove the excess tissue. They may also suffer significant emotional distress, bullying, depression, anxiety, suicidal thoughts, and other harm relating to the formation of breast tissue.

Lawsuits against Ortho-McNeil-Janssen Pharmaceuticals for Risperdal claim the manufacturer knew or reasonably should have known of the risk of the drug stimulating prolactin and causing gynecomastia in patients yet failed to warn consumers. Some lawsuits also cite the drug as causing side effects such as movement disorders (extrapyramidal symptoms), including tremors, restlessness, the inability to move, stiffening of the tongue, and abnormal movement of body parts. These effects may be permanent, even after the patient discontinues the use of Risperdal.

On top of gynecomastia and extrapyramidal symptoms, Risperdal may also cause an increased risk of diabetes, fatigue, dizziness, increased risk of falls, anxiety, difficulty swallowing, nausea, vomiting, and premature mortality in elderly dementia patients. The FDA has issued a black box warning for Risperdal for use in the elderly. The connection between Risperdal and many of these side effects remains unknown. It is the drug maker’s responsibility, however, to conduct appropriate studies and warn consumers of any foreseeable risks and side effects.

Contact Us Today

If you or a loved one has suffered adverse effects or reactions to Risperdal, you may have grounds for a claim against the company. Risperdal lawsuits in the past have forced the manufacturing company to pay more than $2.2 billion in damages for marketing the drug for unapproved uses and criminal activity such as paying physicians kickbacks for prescribing the medication.

A successful lawsuit could result in payment for victims’ related personal injuries, emotional distress, pain and suffering, medical expenses, lost quality of life, and more. Contact our Kansas City lawyers today to discuss your case and potential for financial compensation during a free consultation.